Article 31 Jul 2024 U.S. Senate Unanimously Passes Bill Limiting Number Of Patents Asserted Against Biosimilar Applicants United States IP
Article 09 Jul 2024 Federal Circuit Revives Induced Infringement Claims Despite "Skinny Label" Carve-Out United States Healthcare
Article 12 Oct 2022 USPTO Seeks Public Input On Improving Patent "Robustness And Reliability" United States IP
Article 25 Jan 2022 Inducement Suit Proceeds Against Insurance Company For Encouraging Use Of Generic Drug United States IP
Article 29 Sep 2021 Patent Linkage And Article 76 Proceedings In China: A Litigator's Perspective Worldwide IP
Article 24 Sep 2021 Federal Circuit Vacates Judgment, Reinstates Jury's Verdict Of Induced Infringement United States IP
Article 11 Jul 2018 High Court To Hear Helsinn v. Teva, Resolve AIA Secret Sales Question United States IP
Article 26 Jun 2017 Supreme Court: Biosimilar Applicants May Provide Commercial Marketing Notice Before FDA Approval United States Healthcare